The Caris Precision Oncology Alliance (POA) Executive Committee is responsible for establishing appropriate molecular testing principles to serve as guidelines for the consistent application of tumor profiling across the oncology community. The executive committee is also charged with facilitating collaborative research studies across the POA and coordinating outcome tracking initiatives to generate and document additional medical evidence for the appropriate use and impact of profiling.

Chief Medical Officer, Caris Life Sciences

Executive Director, West Cancer Center

Associate Center Director for Translational Sciences, Karmanos Cancer Institute

Derek Raghavan, MD - Caris COE

President, Levine Cancer Institute

Associate Director for Clinical Research, USC Norris Comprehensive Cancer Center